Relevant bibliographies by topics / Dyshidrosis / Journal articles
To see the other types of publications on this topic, follow the link: Dyshidrosis.

Journal articles on the topic 'Dyshidrosis'

Author: Grafiati
Published: 28 June 2021
Last updated: 2 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Dyshidrosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Wollina, Uwe. "Pompholyx or dyshidrosis." Expert Review of Dermatology 4, no. 4 (August 2009): 403–11. http://dx.doi.org/10.1586/edm.09.34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wilson, M., and T. Maglietta. "Pompholyx (dyshidrosis). A case study." Journal of the American Podiatric Medical Association 75, no. 3 (March 1, 1985): 155–58. http://dx.doi.org/10.7547/87507315-75-3-155.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sudo, K., N. Fujiki, S. Tsuji, M. Ajiki, T. Higashi, M. Niino, S. Kikuchi, F. Moriwaka, and K. Tashiro. "Focal (segmental) dyshidrosis in syringomyelia." Journal of Neurology, Neurosurgery & Psychiatry 67, no. 1 (July 1, 1999): 106–8. http://dx.doi.org/10.1136/jnnp.67.1.106.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lofgren, Sabra M., and Erin M. Warshaw. "Dyshidrosis: Epidemiology, Clinical Characteristics, and Therapy." Dermatitis 17, no. 4 (December 2006): 165–81. http://dx.doi.org/10.2310/6620.2006.05021.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

YERAGANI, VIKRAM K., HITEN PATEL, and M. S. KESHAVAN. "Effectiveness of Desipramine in the Treatment of Dyshidrosis." Journal of Clinical Psychopharmacology 8, no. 1 (February 1988): 76. http://dx.doi.org/10.1097/00004714-198802000-00038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kutzner, Heinz, Reinhard M. Wurzel, and Helmut H. Wolff. "Are Acrosyringia Involved in the Pathogenesis of "Dyshidrosis"?" American Journal of Dermatopathology 8, no. 2 (April 1986): 109–16. http://dx.doi.org/10.1097/00000372-198604000-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hsu, C. Y., Y. C. Wang, and C. H. Kao. "Dyshidrosis is a risk factor for herpes zoster." Journal of the European Academy of Dermatology and Venereology 29, no. 11 (April 27, 2015): 2177–83. http://dx.doi.org/10.1111/jdv.13175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chang, Y. Y., J. van der Velden, G. van der Wier, D. Kramer, G. F. H. Diercks, M. van Geel, P. J. Coenraads, P. L. J. M. Zeeuwen, and M. F. Jonkman. "Keratolysis exfoliativa (dyshidrosis lamellosa sicca): a distinct peeling entity." British Journal of Dermatology 167, no. 5 (October 5, 2012): 1076–84. http://dx.doi.org/10.1111/j.1365-2133.2012.11175.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Radloff, Petra, Dieter Vieluf, Hartwig Mensing, and Johannes Ring. "Erstmanifestation eines bullösen Pemphigoids unter dem Bild einer Dyshidrosis palmoplantaris." Der Hautarzt 45, no. 2 (February 1994): 97–99. http://dx.doi.org/10.1007/pl00013265.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brady, Margaret. "Patient management exchange Hands and feet that blister and peel: Dyshidrosis." Journal of Pediatric Health Care 7, no. 1 (January 1993): 37–38. http://dx.doi.org/10.1016/0891-5245(93)90025-d.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

KIHARA, MIKIHIRO. "Medicine disease and autonomous nerve syndrome. Medicine disease and autonomic neuropathy. Dyshidrosis." Nihon Naika Gakkai Zasshi 84, no. 9 (1995): 1435–37. http://dx.doi.org/10.2169/naika.84.1435.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

ALTUNIŞIK, Nihal. "A Dyshidrosis Case Report That Characterized by Diffuse Blisters on the Bilateral Hands." Turkiye Klinikleri Journal of Medical Sciences 37, no. 4 (2017): 215–16. http://dx.doi.org/10.5336/medsci.2017-57651.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Perretta, Fernando, Norberto Antongiovanni, and Sebastián Jaurretche. "Early Renal Involvement in a Girl with Classic Fabry Disease." Case Reports in Nephrology 2017 (2017): 1–4. http://dx.doi.org/10.1155/2017/9543079.

Full text
Abstract:
Fabry disease is an X-linked lysosomal storage disorder resulting from the deficiency or absence of the enzyme alpha galactosidase A; this defect leads to the systemic accumulation of globotriaosylceramide and its metabolites. Organic involvement in men is well known, but in women it is controversial, mainly due to the random X-chromosome inactivation in each of their cells (Lyon hypothesis). This would explain why women (heterozygotes) present a wide variability in the severity of their phenotype. The manifestations are multisystemic and begin in early childhood, reaching a severe compromise in adulthood. Typical acroparesthesia in hands and feet, gastrointestinal symptoms, angiokeratomas, dyshidrosis, hearing loss, arrhythmias, hypertrophic cardiomyopathy, cerebrovascular accidents, and renal failure can be observed. Nephropathy is one of the major complications of Fabry disease. Glomerular and vascular changes are present before progression to overt proteinuria and decreased glomerular filtration rate, even in pediatric patients. A case of incipient renal involvement in a girl with classic Fabry disease is reported.
APA, Harvard, Vancouver, ISO, and other styles
14

Steele, Haley R., Yanyan Xing, Yuyan Zhu, Henry B. Hilley, Katy Lawson, Yeseul Nho, Taylor Niehoff, and Liang Han. "MrgprC11+ sensory neurons mediate glabrous skin itch." Proceedings of the National Academy of Sciences 118, no. 15 (April 5, 2021): e2022874118. http://dx.doi.org/10.1073/pnas.2022874118.

Full text
Abstract:
Itch arising from glabrous skin (palms and soles) has attracted limited attention within the field due to the lack of methodology. This is despite glabrous itch arising from many medical conditions such as plantar and palmar psoriasis, dyshidrosis, and cholestasis. Therefore, we developed a mouse glabrous skin behavioral assay to investigate the contribution of three previously identified pruriceptive neurons in glabrous skin itch. Our results show that MrgprA3+ and MrgprD+ neurons, although key mediators for hairy skin itch, do not play important roles in glabrous skin itch, demonstrating a mechanistic difference in itch sensation between hairy and glabrous skin. We found that MrgprC11+ neurons are the major mediators for glabrous skin itch. Activation of MrgprC11+ neurons induced glabrous skin itch, while ablation of MrgprC11+ neurons reduced both acute and chronic glabrous skin itch. Our study provides insights into the mechanisms of itch and opens up new avenues for future glabrous skin itch research.
APA, Harvard, Vancouver, ISO, and other styles
15

Brzezinski, Piotr, and Lorenzo Martini. "A phytotherapeutic approach to hand and feet dyshidrosis using vegetables (espcially mashed celeriac applied topically)." Our Dermatology Online 10, e (December 1, 2019): e41.1-e41.2. http://dx.doi.org/10.7241/ourd.2019e.41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Siedler, Gabriela, Ann-Kathrin Káhn, Frank Weidemann, Christoph Wanner, Claudia Sommer, and Nurcan Üçeyler. "Dyshidrosis is associated with reduced amplitudes in electrically evoked pain-related potentials in women with Fabry disease." Clinical Neurophysiology 130, no. 4 (April 2019): 528–36. http://dx.doi.org/10.1016/j.clinph.2019.01.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Ruhin, B., V. Martinot, P. Lafforgue, B. Catteau, S. Manouvrier-Hanu, and J. Ferri. "Pure Ectodermal Dysplasia: Retrospective Study of 16 Cases and Literature Review." Cleft Palate-Craniofacial Journal 38, no. 5 (September 2001): 504–18. http://dx.doi.org/10.1597/1545-1569_2001_038_0504_pedrso_2.0.co_2.

Full text
Abstract:
Objective: To review the possible craniomaxillofacial deformative consequences associated with ectodermal dysplasias and embryonic malformations, which include dental ageneses. Setting: Oral and Maxillofacial Surgery Department, University Hospital, Lille, France. Patients: Sixteen patients (seven boys and nine girls, aged 4 to 34 years) with pure ectodermal dysplasia (no ectodermal dysplasia syndromes). Interventions: All patients had a clinical examination. Seven (two boys and five girls, aged 4 to 25 years) had undergone plaster casts and radiographic and Delaire's cephalometric studies before being treated. Main Outcome Measures: All patients had tooth ageneses (from hypodontia to anodontia), associated with cutaneous dyshidrosis and hair and nail dystrophy. Most of them had a short face, with an unusual facial concavity, a maxillary retrusion, and a relative mandibular protrusion. Management Results and Discussion: Depending on their ages and their orthopedic abnormalities, patients underwent either dental or prosthodontic, orthodontic, orthopedic, orthognathic, or implant treatment. So as not to interfere with the growth pattern, we preferred to reserve implant and orthognathic surgery for full-grown cases. Conclusions: Oral and maxillofacial surgeons must undertake a comprehensive approach to these patients to improve their dental, masticatory, growing, and orthognathic conditions.
APA, Harvard, Vancouver, ISO, and other styles
18

Hotta, Moeko, Teruki Yanagi, Tatsuro Sugai, Shinichi Nakazato, Kentaro Izumi, Hiroo Hata, Kohei Okada, Hideki Goto, Yoshihiro Matsuno, and Hiroshi Shimizu. "Case of peripheral T-cell lymphoma, not otherwise specified, presenting dyshidrosis-like eruptions as the first clinical manifestation." Journal of Dermatology 44, no. 12 (September 4, 2017): e359-e360. http://dx.doi.org/10.1111/1346-8138.14029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Bittencourt, Achiléa L., Karla Mota, Rodrigo F. Oliveira, and Lourdes Farré. "A Dyshidrosis-Like Variant of Adult T-Cell Leukemia/Lymphoma With Clinicopathological Aspects of Mycosis Fungoides. A Case Report." American Journal of Dermatopathology 31, no. 8 (December 2009): 834–37. http://dx.doi.org/10.1097/dad.0b013e3181ac04fe.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Kawada, Morihiro, Yasuhiko Tamada, Hirokazu Simizu, Takeshi Yanagishita, Noriko Yamashita, Natsuko Ishida, Daisuke Watanabe, et al. "Reduction in QSART and vasoactive intestinal polypeptide expression in the skin of Parkinson’s disease patients and its relation to dyshidrosis." Journal of Cutaneous Pathology 36, no. 5 (May 2009): 517–21. http://dx.doi.org/10.1111/j.1600-0560.2008.01086.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Bose, Reetesh, and Jennifer Beecker. "Dyshidrotic eczema in two patients on secukinumab for plaque psoriasis: A case report." SAGE Open Medical Case Reports 8 (January 2020): 2050313X2090456. http://dx.doi.org/10.1177/2050313x20904561.

Full text
Abstract:
Secukinumab was the first fully human anti-interleukin-17a monoclonal antibody and successfully treated moderate-severe psoriasis. These new, targeted, medications are becoming more ubiquitous, but long-term side effects are not fully known. Post-market surveillance is crucial to identify delayed adverse events, analogous to the paradoxical development of pustular psoriasis in a subset of patients treated with the anti-tumor necrosis factor-alpha class drugs. Dyshidrotic eczema and pompholyx are rare variants of dermatitis characterized by vesicles or bullae on the palms, soles and sides of the fingers. The etiology of dyshidrotic eczema is not always known, but medications have been implicated in a minority of patients. Herein, we present two cases of dyshidrotic eczema developing in patients on secukinumab for psoriasis. Extended follow-up and larger numbers of patients are needed to fully understand the potential association between secukinumab and dyshidrotic eczema.
APA, Harvard, Vancouver, ISO, and other styles
22

Martini, Lorenzo, and Texia Research. "The revival of an ancestral galenic preparation called “Ceratum” apt to re-establish the normal viscoelasticity of dermis in perilous skin diseases like iatrogenic dyshidrosis and to treat scars after milia removal." IOSR Journal of Pharmacy and Biological Sciences 11, no. 05 (May 2016): 38–41. http://dx.doi.org/10.9790/3008-1105023841.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Guillet, M. H., Y. Le Ru, G. Guillet, and Morvan Chu. "Resultats d'exploration de 111 dyshidroses." Revue Française d'Allergologie et d'Immunologie Clinique 41, no. 1 (January 2001): 125. http://dx.doi.org/10.1016/s0335-7457(01)80053-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Tchernev, Georgi, Matteo Zanardelli, Cristiana Voicu, Ilko Bakardzhiev, Torello Lotti, Jacopo Lotti, Katlein França, Atanas Batashki, and Uwe Wollina. "Impetiginized Dyshidrotic Eczema." Open Access Macedonian Journal of Medical Sciences 5, no. 4 (July 19, 2017): 539–40. http://dx.doi.org/10.3889/oamjms.2017.081.

Full text
Abstract:
A 16 years old female patient, affected by atopic dermatitis and rhinoconjunctivitis allergica since childhood, requested a dermatologic consultation for lesions which had appeared after 3 months of local treatment with clobethasole propionate. The histological analysis confirmed the diagnosis of dyshidrotic eczema and the microbiological smears demonstrated a significant infection with Staphylococcus aureus. The risk of developing corticosteroids’ side-effects depends on the potency of the product, extended period of use and the volume of product applied. Clobetasol propionate is a group I- highly potent corticosteroid, which should be used for a maximum period of 2 weeks. Several authors have found that this agent has cumulative depot effect, persisting in the epidermis for 4 days after only one application. Taking together these observations, sustained by the clinical case presented above, we can conclude that the infectious risks associated with topical corticosteroid treatment must not be neglected, particularly since treated patients are fragile, and frequently have multiple well-known risk factors.
APA, Harvard, Vancouver, ISO, and other styles
25

Diehl, Joseph, G. Peter Sarantopoulos, and Melvin W. Chiu. "Dyshidrotic mycosis fungoides." Journal of Cutaneous Pathology 38, no. 7 (February 24, 2011): 590–92. http://dx.doi.org/10.1111/j.1600-0560.2011.01682.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Semhoun-Ducloux, Sylvie, Didier Ducloux, and Jean-Philippe Miguet. "Mycophenolate Mofetil-Induced Dyshidrotic Eczema." Annals of Internal Medicine 132, no. 5 (March 7, 2000): 417. http://dx.doi.org/10.7326/0003-4819-132-5-200003070-00015.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Jakob, Thilo, Markus Tiemann, Christoph Kuwert, Dietrich Abeck, Hartwig Mensing, and Johannes Ring. "Dyshidrotic cutaneous T-cell lymphoma." Journal of the American Academy of Dermatology 34, no. 2 (February 1996): 295–97. http://dx.doi.org/10.1016/s0190-9622(96)80139-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Lee, K. C., and B. Ladizinski. "Dyshidrotic eczema following intravenous immunoglobulin treatment." Canadian Medical Association Journal 185, no. 11 (December 3, 2012): E530. http://dx.doi.org/10.1503/cmaj.121036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Anonide, Antonio, David Usiglio, Andrea Pestarina, and Luigi Massone. "Droxicam photosensitivity with dyshidrotic hand dermatitis." International Journal of Dermatology 36, no. 4 (June 28, 2008): 318–20. http://dx.doi.org/10.1111/j.1365-4362.1997.tb03059.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Pickenacker, A. "Dyshidrotic Eczema Treated With Mycophenolate Mofetil." Archives of Dermatology 134, no. 3 (March 1, 1998): 378–79. http://dx.doi.org/10.1001/archderm.134.3.378.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Vocks, E., S. G. Plötz, and J. Ring. "The Dyshidrotic Eczema Area and Severity Index – A Score Developed for the Assessment of Dyshidrotic Eczema." Dermatology 198, no. 3 (1999): 265–69. http://dx.doi.org/10.1159/000018127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Dosseur-Hauteville, Béatrice. "Traitement de la dyshidrose par aromathérapie." Revue du Podologue 15, no. 86 (March 2019): 29–31. http://dx.doi.org/10.1016/j.revpod.2019.01.012.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Chang, Claire H., and Philip R. Cohen. "Ipsilateral post-cast hypertrichosis and dyshidrotic dermatitis." Archives of Physical Medicine and Rehabilitation 76, no. 1 (January 1995): 97–100. http://dx.doi.org/10.1016/s0003-9993(95)80050-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Lehucher-Michel, M. P., M. C. Koeppel, A. Lanteaume, and J. Sayag. "Dyshidrotic eczema and occupation: a descriptive study." Contact Dermatitis 43, no. 4 (October 2000): 200–205. http://dx.doi.org/10.1034/j.1600-0536.2000.043004200.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Letić, Milorad. "Use of Sunlight to Treat Dyshidrotic Eczema." JAMA Dermatology 149, no. 5 (May 1, 2013): 634. http://dx.doi.org/10.1001/jamadermatol.2013.2772.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Stuckert, Joseph, and Susan Nedorost. "Low-cobalt diet for dyshidrotic eczema patients." Contact Dermatitis 59, no. 6 (December 2008): 361–65. http://dx.doi.org/10.1111/j.1600-0536.2008.01469.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

KHLEBNIKOVA, A. N. "ROLE OF PROTECTIVE TOPICAL AGENTS IN THERAPY OF CHRONIC DERMATOSES." Russian Journal of Allergy 11, no. 3 (December 15, 2014): 47–52. http://dx.doi.org/10.36691/rja512.

Full text
Abstract:
Epidermal barrier insufficiency results in skin dryness and fissures in different chronic dermatoses. Barrier dysfunction is due either to genetic problems or lipid deficiency or damage of tight junction proteins. Here we discuss various abnormalities of epidermal barrier in eczema and psoriasis which necessitate to prescribe pro- tective and moisturizing agents to restore skin barrier. We give our own practice data of using Bariederm cream and balm in combined therapy of dyshidrotic eczema, plantar eczema and palmoplantar psoriasis.
APA, Harvard, Vancouver, ISO, and other styles
38

Kotan, D., T. Erdem, B. A. Acar, and A. Boluk. "Dyshidrotic eczema associated with the use of IVIg." Case Reports 2013, feb15 1 (February 15, 2013): bcr2012008001. http://dx.doi.org/10.1136/bcr-2012-008001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Fowler, Joseph F., and Frances J. Storrs. "Nickel Allergy and Dyshidrotic Eczema: Are They Related?" Dermatitis 12, no. 2 (June 2001): 119–21. http://dx.doi.org/10.1097/01206501-200106000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Fowler, Joseph F., and Frances J. Storrs. "Nickel Allergy and Dyshidrotic Eczema: Are They Related?" American Journal of Contact Dermatitis 12, no. 2 (June 2001): 119–21. http://dx.doi.org/10.1097/01634989-200106000-00011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Reis, Joel, Inês Lobo, André Coelho, and Manuela Selores. "Successful treatment of recalcitrant dyshidrotic eczema with oxybutynin." International Journal of Dermatology 59, no. 8 (May 9, 2020): 1010–12. http://dx.doi.org/10.1111/ijd.14928.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Fowler, J. "Nickel allergy and dyshidrotic eczema: Are they related?" American Journal of Contact Dermatitis 12, no. 2 (June 2001): 119–21. http://dx.doi.org/10.1053/ajcd.2001.23123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Bienvenu, Anne-Lise, and Stéphane Picot. "La dyshidrose : de la sueur et des larmes." Revue du Podologue 13, no. 74 (March 2017): 29–30. http://dx.doi.org/10.1016/j.revpod.2016.12.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Bizunova, M. A., N. G. Ilina, D. V. Demina, Yu M. Krinitsyna, and I. G. Sergeeva. "Food allergy and sensitization in patients with dyshidrotic eczema." Klinicheskaya dermatologiya i venerologiya 16, no. 5 (2017): 31. http://dx.doi.org/10.17116/klinderma201716531-34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Shin, Yoon-Jin, and Jong-Woo Lee. "Clinical Analysis on the 219 cases of Dyshidrotic Eczema." Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology 27, no. 4 (November 25, 2014): 58–66. http://dx.doi.org/10.6114/jkood.2014.27.4.058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Letić, Milorad. "Exposure to sunlight as adjuvant therapy for dyshidrotic eczema." Medical Hypotheses 73, no. 2 (August 2009): 203–4. http://dx.doi.org/10.1016/j.mehy.2008.08.035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Klein, Arnold William. "Treatment of dyshidrotic hand dermatitis with intradermal botulinum toxin." Journal of the American Academy of Dermatology 50, no. 1 (January 2004): 153–54. http://dx.doi.org/10.1016/s0190-9622(03)01674-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Basseri, Sana, Thai Yen Ly, and Peter R. Hull. "Dyshidrotic Bullous Pemphigoid: Case Report and Review of Literature." Journal of Cutaneous Medicine and Surgery 22, no. 6 (March 5, 2018): 614–17. http://dx.doi.org/10.1177/1203475418763544.

Full text
Abstract:
Background: Dyshidrotic pemphigoid (DP) is a rare variant of bullous pemphigoid (BP) that affects the hands and feet and may resemble an acute vesicular eczema. While it can remain confined to hands and feet, spread that involves the entire body is described. BP and DP are associated with autoantibodies directed against hemidesmosomal proteins BP180 (collagen XVII) and BP230 (dystonin), which are transmembrane and intracellular proteins in the basement membrane zone, respectively. Case Summary: We present a case of DP in a 78-year-old woman who was diagnosed based on histopathologic and immunofluorescence findings and subsequently successfully treated. Conclusion: DP is an unusual form of localized BP. While the pathogenesis is still unclear, it may involve differential expression of BP antigens in the cutaneous basement membrane of the hands and feet. The clinical presentation is a diagnostic challenge, and skin biopsies with immunofluorescence studies are required for diagnosis.
APA, Harvard, Vancouver, ISO, and other styles
49

Sherertz, Elizabeth F., and Katherine B. Medford. "Patch Testing May be Valuable in Chronic Dyshidrotic Eczema." Dermatitis 5, no. 3 (September 1994): 180–81. http://dx.doi.org/10.1097/01206501-199409000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Sherertz, Elizabeth F., and Katherine B. Medford. "Patch Testing May be Valuable in Chronic Dyshidrotic Eczema." American Journal of Contact Dermatitis 5, no. 3 (September 1994): 180–81. http://dx.doi.org/10.1097/01634989-199409000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography